253 related articles for article (PubMed ID: 16267130)
1. The antiinflammatory effect of laminar flow: the role of PPARgamma, epoxyeicosatrienoic acids, and soluble epoxide hydrolase.
Liu Y; Zhang Y; Schmelzer K; Lee TS; Fang X; Zhu Y; Spector AA; Gill S; Morisseau C; Hammock BD; Shyy JY
Proc Natl Acad Sci U S A; 2005 Nov; 102(46):16747-52. PubMed ID: 16267130
[TBL] [Abstract][Full Text] [Related]
2. Laminar flow activates peroxisome proliferator-activated receptor-gamma in vascular endothelial cells.
Liu Y; Zhu Y; Rannou F; Lee TS; Formentin K; Zeng L; Yuan X; Wang N; Chien S; Forman BM; Shyy JY
Circulation; 2004 Aug; 110(9):1128-33. PubMed ID: 15313948
[TBL] [Abstract][Full Text] [Related]
3. Adenosine A2A receptor modulates vascular response in soluble epoxide hydrolase-null mice through CYP-epoxygenases and PPARγ.
Nayeem MA; Pradhan I; Mustafa SJ; Morisseau C; Falck JR; Zeldin DC
Am J Physiol Regul Integr Comp Physiol; 2013 Jan; 304(1):R23-32. PubMed ID: 23152114
[TBL] [Abstract][Full Text] [Related]
4. 17,18-epoxyeicosatetraenoic acid targets PPARγ and p38 mitogen-activated protein kinase to mediate its anti-inflammatory effects in the lung: role of soluble epoxide hydrolase.
Morin C; Sirois M; Echavé V; Albadine R; Rousseau E
Am J Respir Cell Mol Biol; 2010 Nov; 43(5):564-75. PubMed ID: 20008283
[TBL] [Abstract][Full Text] [Related]
5. A potent soluble epoxide hydrolase inhibitor, t-AUCB, acts through PPARγ to modulate the function of endothelial progenitor cells from patients with acute myocardial infarction.
Xu DY; Davis BB; Wang ZH; Zhao SP; Wasti B; Liu ZL; Li N; Morisseau C; Chiamvimonvat N; Hammock BD
Int J Cardiol; 2013 Aug; 167(4):1298-304. PubMed ID: 22525341
[TBL] [Abstract][Full Text] [Related]
6. Activation of peroxisome proliferator-activated receptor alpha by substituted urea-derived soluble epoxide hydrolase inhibitors.
Fang X; Hu S; Watanabe T; Weintraub NL; Snyder GD; Yao J; Liu Y; Shyy JY; Hammock BD; Spector AA
J Pharmacol Exp Ther; 2005 Jul; 314(1):260-70. PubMed ID: 15798002
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of soluble epoxide hydrolase does not protect against endotoxin-mediated hepatic inflammation.
Fife KL; Liu Y; Schmelzer KR; Tsai HJ; Kim IH; Morisseau C; Hammock BD; Kroetz DL
J Pharmacol Exp Ther; 2008 Dec; 327(3):707-15. PubMed ID: 18815352
[TBL] [Abstract][Full Text] [Related]
8. High salt diet modulates vascular response in A2AAR (+/+) and A 2AAR (-/-) mice: role of sEH, PPARγ, and K ATP channels.
Pradhan I; Ledent C; Mustafa SJ; Morisseau C; Nayeem MA
Mol Cell Biochem; 2015 Jun; 404(1-2):87-96. PubMed ID: 25739357
[TBL] [Abstract][Full Text] [Related]
9. Epoxyeicosatrienoic Acids Inhibit the Activation of Murine Fibroblasts by Blocking the TGF-
Tao JH; Liu T; Zhang CY; Zu C; Yang HH; Liu YB; Yang JT; Zhou Y; Guan CX
Oxid Med Cell Longev; 2022; 2022():7265486. PubMed ID: 36275905
[TBL] [Abstract][Full Text] [Related]
10. Ablation of soluble epoxide hydrolase reprogram white fat to beige-like fat through an increase in mitochondrial integrity, HO-1-adiponectin in vitro and in vivo.
Liu L; Puri N; Raffaele M; Schragenheim J; Singh SP; Bradbury JA; Bellner L; Vanella L; Zeldin DC; Cao J; Abraham NG
Prostaglandins Other Lipid Mediat; 2018 Sep; 138():1-8. PubMed ID: 30041041
[TBL] [Abstract][Full Text] [Related]
11. Effect of Soluble Epoxide Hydrolase on the Modulation of Coronary Reactive Hyperemia: Role of Oxylipins and PPARγ.
Hanif A; Edin ML; Zeldin DC; Morisseau C; Nayeem MA
PLoS One; 2016; 11(9):e0162147. PubMed ID: 27583776
[TBL] [Abstract][Full Text] [Related]
12. Deletion of soluble epoxide hydrolase enhances coronary reactive hyperemia in isolated mouse heart: role of oxylipins and PPARγ.
Hanif A; Edin ML; Zeldin DC; Morisseau C; Nayeem MA
Am J Physiol Regul Integr Comp Physiol; 2016 Oct; 311(4):R676-R688. PubMed ID: 27488890
[TBL] [Abstract][Full Text] [Related]
13. Activation of peroxisome proliferator-activated receptor-γ downregulates soluble epoxide hydrolase in cardiomyocytes.
Pang W; Li N; Ai D; Niu XL; Guan YF; Zhu Y
Clin Exp Pharmacol Physiol; 2011 Jun; 38(6):358-64. PubMed ID: 21291492
[TBL] [Abstract][Full Text] [Related]
14. Epoxyeicosatrienoic acids and the soluble epoxide hydrolase are determinants of pulmonary artery pressure and the acute hypoxic pulmonary vasoconstrictor response.
Keserü B; Barbosa-Sicard E; Popp R; Fisslthaler B; Dietrich A; Gudermann T; Hammock BD; Falck JR; Weissmann N; Busse R; Fleming I
FASEB J; 2008 Dec; 22(12):4306-15. PubMed ID: 18725458
[TBL] [Abstract][Full Text] [Related]
15. Soluble epoxide hydrolase: a novel therapeutic target in stroke.
Zhang W; Koerner IP; Noppens R; Grafe M; Tsai HJ; Morisseau C; Luria A; Hammock BD; Falck JR; Alkayed NJ
J Cereb Blood Flow Metab; 2007 Dec; 27(12):1931-40. PubMed ID: 17440491
[TBL] [Abstract][Full Text] [Related]
16. A potent soluble epoxide hydrolase inhibitor, t-AUCB, modulates cholesterol balance and oxidized low density lipoprotein metabolism in adipocytes in vitro.
Shen L; Peng H; Zhao S; Xu D
Biol Chem; 2014 Apr; 395(4):443-51. PubMed ID: 24225128
[TBL] [Abstract][Full Text] [Related]
17. Novel mechanism of brain soluble epoxide hydrolase-mediated blood pressure regulation in the spontaneously hypertensive rat.
Sellers KW; Sun C; Diez-Freire C; Waki H; Morisseau C; Falck JR; Hammock BD; Paton JF; Raizada MK
FASEB J; 2005 Apr; 19(6):626-8. PubMed ID: 15659536
[TBL] [Abstract][Full Text] [Related]
18. Soluble epoxide hydrolase is a main effector of angiotensin II-induced hypertension.
Jung O; Brandes RP; Kim IH; Schweda F; Schmidt R; Hammock BD; Busse R; Fleming I
Hypertension; 2005 Apr; 45(4):759-65. PubMed ID: 15699457
[TBL] [Abstract][Full Text] [Related]
19. Vascular repair and anti-inflammatory effects of soluble epoxide hydrolase inhibitor.
Dai N; Zhao C; Kong Q; Li D; Cai Z; Wang M
Exp Ther Med; 2019 May; 17(5):3580-3588. PubMed ID: 30988740
[TBL] [Abstract][Full Text] [Related]
20. [Soluble epoxide hydrolase and lipid metabolism].
Ma XX; Liu Y; Zhu Y
Sheng Li Ke Xue Jin Zhan; 2010 Aug; 41(4):267-71. PubMed ID: 21416942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]